Dominick Colangelo

Insider Reports History

Location
1000 Winter St., Suite 2200, Waltham, MA
Signature
/s/ Christopher Galletta, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Dominick Colangelo:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Vericel Corp President and CEO, Director Common Stock 260K $10.8M $41.53 May 15, 2025 Direct
Vericel Corp President and CEO, Director Restricted Stock Unit 54.8K $2.85M $52.07 Feb 24, 2025 Direct
Trevi Therapeutics, Inc. Director Nonstatutory Stock Option (right to buy) 45K Jun 11, 2025 Direct
Vericel Corp President and CEO, Director Stock Option (Right to Buy) 0 May 15, 2025 Direct

Insider Reports Filed by Dominick Colangelo

Symbol Company Period Transactions Value $ Form Type Date Filed Role
TRVI Trevi Therapeutics, Inc. Jun 11, 2025 1 $0 4 Jun 13, 2025 Director
VCEL Vericel Corp May 14, 2025 6 -$1.1M 4 May 16, 2025 President and CEO, Director
VCEL Vericel Corp Apr 9, 2025 6 -$1.93M 4 Apr 11, 2025 President and CEO, Director
VCEL Vericel Corp Mar 12, 2025 6 -$2.35M 4 Mar 14, 2025 President and CEO, Director
VCEL Vericel Corp Feb 24, 2025 3 -$443K 4 Feb 26, 2025 President and CEO, Director
VCEL Vericel Corp Feb 20, 2025 2 $0 4 Feb 24, 2025 President and CEO, Director
VCEL Vericel Corp Feb 18, 2025 8 -$553K 4 Feb 20, 2025 President and CEO, Director
VCEL Vericel Corp Nov 13, 2024 6 -$1.81M 4 Nov 15, 2024 President and CEO, Director
VCEL Vericel Corp Oct 16, 2024 6 -$1.32M 4 Oct 18, 2024 President and CEO, Director
VCEL Vericel Corp Sep 11, 2024 6 -$1.42M 4 Sep 13, 2024 President and CEO, Director
VCEL Vericel Corp Aug 14, 2024 6 -$1.49M 4 Aug 16, 2024 President and CEO, Director
VCEL Vericel Corp Jul 17, 2024 6 -$1.7M 4 Jul 19, 2024 President and CEO, Director
TRVI Trevi Therapeutics, Inc. Jun 13, 2024 1 $0 4 Jun 14, 2024 Director
VCEL Vericel Corp Jun 12, 2024 6 -$1.42M 4 Jun 14, 2024 President and CEO, Director
VCEL Vericel Corp May 15, 2024 6 -$1.6M 4 May 17, 2024 President and CEO, Director
VCEL Vericel Corp Apr 30, 2024 6 $300K 4 May 1, 2024 President and CEO, Director
VCEL Vericel Corp Apr 17, 2024 6 -$1.49M 4 Apr 19, 2024 President and CEO, Director
VCEL Vericel Corp Mar 13, 2024 6 -$1.45M 4 Mar 15, 2024 President and CEO, Director
VCEL Vericel Corp Feb 22, 2024 2 $0 4 Feb 26, 2024 President and CEO, Director
VCEL Vericel Corp Feb 20, 2024 9 -$892K 4 Feb 22, 2024 President and CEO, Director
VCEL Vericel Corp Feb 14, 2024 6 -$1.57M 4 Feb 16, 2024 President and CEO, Director
VCEL Vericel Corp Feb 12, 2024 3 -$165K 4 Feb 13, 2024 President and CEO, Director
VCEL Vericel Corp Jan 17, 2024 6 -$1.18M 4 Jan 19, 2024 President and CEO, Director
VCEL Vericel Corp Dec 13, 2023 7 -$768K 4 Dec 15, 2023 President and CEO, Director
VCEL Vericel Corp Dec 6, 2023 6 -$746K 4 Dec 8, 2023 President and CEO, Director
TRVI Trevi Therapeutics, Inc. Jun 28, 2023 1 $0 4 Jun 30, 2023 Director
VCEL Vericel Corp Feb 17, 2023 9 -$285K 4 Feb 22, 2023 President and CEO, Director
VCEL Vericel Corp Feb 11, 2023 3 -$103K 4 Feb 14, 2023 President and CEO, Director
VCEL Vericel Corp Feb 6, 2023 3 -$99.5K 4 Feb 8, 2023 President and CEO, Director
VCEL Vericel Corp Jan 10, 2023 3 -$53.2K 4 Jan 12, 2023 President and CEO, Director
TRVI Trevi Therapeutics, Inc. Jun 23, 2022 1 $0 4/A Jul 1, 2022 Director
VCEL Vericel Corp Feb 18, 2022 6 -$447K 4 Feb 22, 2022 President and CEO, Director
VCEL Vericel Corp Feb 11, 2022 3 -$379K 4 Feb 15, 2022 President and CEO, Director
VCEL Vericel Corp Feb 6, 2022 3 -$339K 4 Feb 8, 2022 President and CEO, Director
TRVI Trevi Therapeutics, Inc. Jun 16, 2021 1 $0 4 Jun 17, 2021 Director